Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.
Related Posts
Blue Origin’s first New Glenn rocket reaches orbit, misses booster landing
Blue Origin launched its towering New Glenn rocket for the first time early Monday, in a crucial milestone for Jeff Bezos’ space company.
United Airlines raises spending requirements to earn frequent flyer status
United Airlines customers will have to spend and fly more to earn elite benefits next year.
SpaceX faces opposition to Starlink expansion from Ukrainian group concerned about Musk ties to Russia
A Ukrainian-American group filed a petition with the FCC to try and keep Starlink from putting almost 22,500 satellites into orbit until further review.